“GLP-1 receptor agonist drugs as a protective factor against chronic kidney disease in patients with type 2 diabetes mellitus”, RSD, vol. 10, no. 16, p. e134101623517, Dec. 2021, doi: 10.33448/rsd-v10i16.23517.